» Articles » PMID: 39866586

Improving Reproductive Outcomes in Frozen Embryo Transfer over Fresh Embryo Transfer in Women with Endometrioma: A Historical Cohort Study

Overview
Date 2025 Jan 27
PMID 39866586
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endometrioma, a common manifestation of endometriosis, often indicates the severity of the disease. In vitro fertilization and embryo transfer (ET) are key therapeutic strategies for infertility associated with endometriosis. However, the optimal type of ET (frozen or fresh) and its impact on pregnancy success rates remain debated, with limited studies available.

Objective: This historical cohort study aimed to compare fertility and neonatal outcomes, focusing on live birth rate (LBR), clinical pregnancy, and implantation rates in women with endometrioma-associated infertility, between fresh and frozen embryo transfer (FET).

Materials And Methods: In this historical cohort study, the medical records (files) of 289 women diagnosed with endometrioma-related infertility, who underwent in vitro fertilization/intracytoplasmic sperm injection treatment at Royan Institute, Tehran, Iran between March 2016-2021 were reviewed. Ultimately, 200 files that met the established criteria were selected for review. The extracted data was then compared between groups: FET (n = 121) and fresh ET (n = 79).

Results: No significant differences were observed between the groups in terms of demographic characteristics and endometrioma size. The only significant difference in fertility outcomes was the LBR, which was 36.4% for the FET group compared to 22.8% for the fresh ET group (p = 0.04). No significant differences were observed in neonatal outcomes between the groups. Overall, our study suggests that FET may lead to higher LBRs in women diagnosed with endometrioma.

Conclusion: Our study suggests that FET may lead to higher LBRs in women diagnosed with endometrioma.

References
1.
Zhang W, Xie D, Zhang H, Huang J, Xiao X, Wang B . Cumulative Live Birth Rates After the First ART Cycle Using Flexible GnRH Antagonist Protocol vs. Standard Long GnRH Agonist Protocol: A Retrospective Cohort Study in Women of Different Ages and Various Ovarian Reserve. Front Endocrinol (Lausanne). 2020; 11:287. PMC: 7225261. DOI: 10.3389/fendo.2020.00287. View

2.
Pan D, Yang J, Zhang N, Wang L, Li N, Shi J . Gonadotropin-releasing hormone agonist downregulation combined with hormone replacement therapy improves the reproductive outcome in frozen-thawed embryo transfer cycles for patients of advanced reproductive age with idiopathic recurrent.... Reprod Biol Endocrinol. 2022; 20(1):26. PMC: 8812179. DOI: 10.1186/s12958-022-00897-3. View

3.
Salemi S, Yahyaei A, Vesali S, Ghaffari F . Endometrial preparation for vitrified-warmed embryo transfer with or without GnRH-agonist pre-treatment in patients with polycystic ovary syndrome: a randomized controlled trial. Reprod Biomed Online. 2021; 43(3):446-452. DOI: 10.1016/j.rbmo.2021.06.006. View

4.
Zheng D, Zeng L, Yang R, Lian Y, Zhu Y, Liang X . Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI-ICSI): protocol for a multicentre randomised controlled trial. BMJ Open. 2019; 9(9):e030366. PMC: 6773417. DOI: 10.1136/bmjopen-2019-030366. View

5.
Utsunomiya T, Ito H, Nagaki M, Sato J . A prospective, randomized study: day 3 versus hatching blastocyst stage. Hum Reprod. 2004; 19(7):1598-603. DOI: 10.1093/humrep/deh288. View